Financhill
Sell
21

IPSC Quote, Financials, Valuation and Earnings

Last price:
$0.57
Seasonality move :
-30.11%
Day range:
$0.51 - $0.53
52-week range:
$0.34 - $1.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.40x
P/B ratio:
0.26x
Volume:
463.2K
Avg. volume:
1.3M
1-year change:
-63.24%
Market cap:
$45.9M
Revenue:
$6.6M
EPS (TTM):
-$0.31

Earnings Data

Next earnings date for IPSC
Mar 19
2026
Most recent earnings per share
-$0.40
Missed by $0.01
(Nov 13/2025)
Consensus Estimate
-$0.39
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IPSC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/19/2026 Q4 -$83.3K -- -- -$0.24 --
11/13/2025 Q3 -- -- -$0.40 -$0.39 -$0.01
08/14/2025 Q2 -- -- -$0.38 -$0.38 -$0.00
05/15/2025 Q1 $49.6M $109.2M $0.89 $0.18 $0.71
03/19/2025 Q4 $975K $4.2M -$0.42 -$0.44 $0.01
11/05/2024 Q3 $550K $791K -$0.37 -$0.45 $0.08
08/08/2024 Q2 $666.7K $771K -$0.38 -$0.50 $0.12
05/09/2024 Q1 $225K $855K -$0.45 -$0.45 --
03/14/2024 Q4 $1.9M $268K -$0.65 -$0.53 -$0.12
11/09/2023 Q3 -- -- -$0.55 -$0.49 -$0.06
08/09/2023 Q2 -- -- -$0.56 -$0.54 -$0.02
05/11/2023 Q1 -- -- -$0.53 -$0.52 -$0.01
03/16/2023 Q4 -- -- -$0.55 -$0.58 $0.03
11/10/2022 Q3 -- -- -$0.53 -$0.60 $0.07
08/11/2022 Q2 -- -- -$0.54 -$0.50 -$0.04
05/16/2022 Q1 -- -- -$0.66 -$0.54 -$0.12
03/17/2022 Q4 -- -- -$0.51 -$0.49 -$0.02
11/10/2021 Q3 -- -- -$0.48 -$0.42 -$0.06
08/12/2021 Q2 -- -- -$1.93 -$0.38 -$1.55
03/31/2021 Q1 -- -- -$0.44 -- --
12/31/2020 Q4 -- -- -$0.37 -- --

Century Therapeutics, Inc. Earnings Questions

  • How Much did Century Therapeutics, Inc. Generate in Revenue Last Quarter?

    Century Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Century Therapeutics, Inc. Beat Earnings Last Quarter?

    Century Therapeutics, Inc. announced earnings per share of -$0.40 which represents a miss of analyst forecast a -$0.39 per share.

  • Is Century Therapeutics, Inc. Profitable?

    Century Therapeutics, Inc. reported -$3.1M that represents -$0.04 per share over the last quarter.

  • What is the Analyst Consensus for Century Therapeutics, Inc. EPS Next Year?

    Century Therapeutics, Inc.'s earnings are forecast to decrease from -$1.61 per share to -$1.63 per share next year representing a decrease of -87.57%.

  • When is Century Therapeutics, Inc.'s Earnings Date?

    Century Therapeutics, Inc.'s next earnings date is March 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 5.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock